Idiopathic Granulomatous Mastitis: Overcoming this Important Clinical Challenge

dc.authoridAkbulut, Sami/0000-0002-6864-7711
dc.authoridkale, ilhami taner/0000-0002-1522-8361
dc.authorwosidEmre, Arif/JME-3234-2023
dc.authorwosidAkbulut, Sami/L-9568-2014
dc.authorwosidkale, ilhami taner/C-8883-2014
dc.contributor.authorEmre, Arif
dc.contributor.authorAkbulut, Sami
dc.contributor.authorSertkaya, Mehmet
dc.contributor.authorBitiren, Muharrem
dc.contributor.authorKale, Ilhami Taner
dc.contributor.authorBulbuloglu, Ertan
dc.contributor.authorYurttutan, Nursel
dc.date.accessioned2024-08-04T20:47:04Z
dc.date.available2024-08-04T20:47:04Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThe aim of this study was to determine possible risk factors for recurrence development in patients with idiopathic granulomatous mastitis (IGM). Demographic, clinical, radiologic, and histopathologic characteristics of 34 consecutive patients with IGM were retrospectively reviewed. Also, 32 patients who were informed about recurrence status were divided into non-recurrent (n = 27) and recurrent (n = 5) groups. Both groups were compared for demographic and clinical parameters. This study included 34 female patients with IGM aged between 26 and 70 years (median: 38 years). During the follow-up period, no recurrence occurred in 27 patients whereas recurrence developed in 5 patients. No significant difference was found between the groups with respect to age, lesion size, breast-feeding, number of child, marital status, use of oral contraceptive, familial or personal tuberculosis history, PPD test, smoking, lesion side, lesion location on the breast, and treatment choice. The diagnostic tools of the IGM as follows: tru-cut (n = 18); incisional (n = 6); tru-cut + incisional (n = 5); tru-cut + excisional (n = 2); tru-cut + FNAB (n = 1); FNAB + excisional (n = 1) and FNAB (n = 1). Treatment options were as follow: antibiotics + drainage (n = 10); antibiotics + drainage + corticosteroid (n = 9); wait and watch (n = 6); corticosteroid (n = 3); antibiotics + antituberculous (n = 1); antituberculous (n = 1); antibiotics + breast conserving surgery + chemotherapy (n = 1); modified radical mastectomy+ chemotherapy+ radiotherapy (n=1); and no available (n = 2). This study shows that no demographic and clinical data contributes to the development of recurrence disease. To give a strong message, this study should be supported by other high volume and prospective studies.en_US
dc.identifier.doi10.9738/INTSURG-D-16-00225.1
dc.identifier.endpage237en_US
dc.identifier.issn0020-8868
dc.identifier.issue5-6en_US
dc.identifier.scopus2-s2.0-85077933751en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage228en_US
dc.identifier.urihttps://doi.org/10.9738/INTSURG-D-16-00225.1
dc.identifier.urihttps://hdl.handle.net/11616/99147
dc.identifier.volume103en_US
dc.identifier.wosWOS:000480415700002en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherInt College Of Surgeonsen_US
dc.relation.ispartofInternational Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectIdiopathic Granulomatous Mastitisen_US
dc.subjectCorticosteroidsen_US
dc.subjectRecurrenceen_US
dc.titleIdiopathic Granulomatous Mastitis: Overcoming this Important Clinical Challengeen_US
dc.typeArticleen_US

Dosyalar